Thompson Rahsaan

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-05-13	2026-05-11	Zevra Therapeutics Inc (ZVRA)	PlS Planned sale	90,919 -21.7% 346.28 US$3,062,126	90,919 -21.7%	346.28	US$3,062,126
2026-05-11	2026-05-11	Zevra Therapeutics Inc (ZVRA)	PrS Proposed sale	63,016 181.52 US$1,606,183	63,016	181.52	US$1,606,183
2026-02-02	2026-01-30	Zevra Therapeutics Inc (ZVRA)	PlS Planned sale	79,330 -4.6% 486.50 US$4,152,739	79,330 -4.6%	486.50	US$4,152,739
2026-01-30	2026-01-30	Zevra Therapeutics Inc (ZVRA)	PrS Proposed sale	4,080 8.86 US$36,149	4,080	8.86	US$36,149
2025-06-30	2025-06-26	Zevra Therapeutics Inc (ZVRA)	PlS Planned sale	24,000 -36.0% 9.21 US$221,004	24,000 -36.0%	9.21	US$221,004
2025-06-26	2025-06-26	Zevra Therapeutics Inc (ZVRA)	PrS Proposed sale	24,000 9.33 US$223,920	24,000	9.33	US$223,920